3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
102
Neoplasms, Plasma Cell
12
Recurrence
9
Lymphoma
8
Immunoglobulin Light-chain Amyloidosis
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
5
Leukemia, Myeloid, Acute
5
Lymphoma, Mantle-Cell
4
Waldenstrom Macroglobulinemia
3
Paraproteinemias
3
Hematologic Neoplasms
3
Amyloidosis
3
Renal Insufficiency
2
Myelodysplastic Syndromes
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Burkitt Lymphoma
2
beta-Thalassemia
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thalassemia
1
Sarcoma, Myeloid
1
Prostatic Neoplasms
1
Plasmacytoma
1
Plasmablastic Lymphoma
1
Peripheral Nervous System Diseases
1
Interventions
Cytarabine
3
Injections
2
Idarubicin
2
Gemtuzumab
2
Filgrastim
2
Decitabine
2
veliparib
1
fludarabine phosphate
1
aldesleukin
1
Whole-Body Irradiation
1
Temozolomide
1
Peripheral Blood Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Etoposide
1
Daunorubicin
1
CPX-351
1
Busulfan
1
Bone Marrow Transplantation
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Acute
×
Bortezomib
×
1 year
×
Clear all
No trials found.